NovaBay Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €13.48M +∞% -€2.18M -∞% -16.2% -0.16 pp N/A N/A
    (estimated) N/A N/A N/A N/A N/A
    €8.34M -6.4% -€6.16M -25.1% -73.8% +0.18 pp -€4.42M +25.9% -52.9% -0.14 pp
    €8.92M -27.4% -€8.22M -40.7% -92.2% +0.21 pp -€3.51M -37.1% -39.3% +0.061 pp
    €12.29M +71.0% -€13.87M +148.0% -112.9% -0.35 pp -€5.58M -28.4% -45.4% +0.63 pp
    €7.18M -15.2% -€5.59M -40.6% -77.9% +0.33 pp -€7.80M +94.7% -108.5% -0.61 pp
    €8.47M +50.5% -€9.42M +5.3% -111.1% +0.48 pp -€4.00M -40.6% -47.3% +0.73 pp
    €5.63M -47.2% -€8.94M +60.2% -158.9% -1.1 pp -€6.75M +43.2% -119.9% -0.76 pp
    €10.67M -31.4% -€5.58M -11.6% -52.3% -0.12 pp -€4.71M -8.3% -44.2% -0.11 pp
    €15.55M +53.2% -€6.31M -43.7% -40.6% +0.70 pp -€5.14M -49.7% -33.1% +0.68 pp
    €10.15M +171.6% -€11.22M -30.7% -110.5% +3.2 pp -€10.21M -35.0% -100.7% +3.2 pp
    €3.74M +315.7% -€16.18M +24.9% -433.1% +10 pp -€15.73M +23.0% -420.8% +10 pp
    €899.01K -69.7% -€12.96M -5.3% -1,441.6% -9.8 pp -€12.78M +16.8% -1,421.9% -11 pp
    €2.97M -49.9% -€13.68M +128.3% -461.4% -3.6 pp -€10.94M +101.1% -368.9% -2.8 pp
    €5.93M -37.0% -€5.99M +38.2% -101.2% -0.55 pp -€5.44M +111.0% -91.8% -0.64 pp
    €9.40M +13.0% -€4.34M +18.0% -46.1% -0.020 pp -€2.58M -235.5% -27.4% -0.50 pp
    €8.32M -37.8% -€3.67M -259.7% -44.2% -0.61 pp €1.90M -343.3% 22.9% +0.29 pp
    €13.38M +133.3% €2.30M -133.2% 17.2% +1.4 pp -€782.16K -90.2% -5.8% +1.3 pp
    €5.73M +13.7% -€6.92M +50.3% -120.7% -0.29 pp -€7.96M +66.4% -138.8% -0.44 pp
    €5.04M +285.7% -€4.61M +2.2% -91.3% +2.5 pp -€4.78M -209.8% -94.8% -4.3 pp
    €1.31M +∞% -€4.51M +52.6% -344.8% -3.4 pp €4.36M -264.3% 333.1% +3.3 pp
    €0.00 -€2.95M N/A -€2.65M N/A

    Notifications